Vintilă Bogdan Ioan, Anghel Claudia Elena, Sava Mihai, Bereanu Alina-Simona, Codru Ioana Roxana, Stoica Raul, Vulcu Mihai Alexandra-Maria, Grama Andreea-Maria, Cătană Alina Camelia, Boicean Adrian Gheorghe, Hașegan Adrian, Mihețiu Alin, Băcilă Ciprian-Ionuț
Faculty of Medicine, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania.
County Clinical Emergency Hospital of Sibiu, 550245 Sibiu, Romania.
J Clin Med. 2024 Oct 19;13(20):6253. doi: 10.3390/jcm13206253.
: Electroconvulsive therapy (ECT) is a well-established treatment for various psychiatric disorders. This retrospective study evaluates anesthesia practices, patient characteristics, and outcomes in ECT over a two-year period at the "Dr. Gheorghe Preda" Clinical Psychiatry Hospital in Sibiu, Romania. : From March 2022 to July 2024, the Neuroscience Scientific Research Collective at our institution carried out a retrospective observational study on patients who underwent ECT. The evaluation and treatment protocol involved patients from all over the country. The study involved 30 patients aged between 22 and 67 years and a mean age of 39.4 years; among them, 57% were male. The majority of the patients (68%) lived in urban areas, and 80% came from a different county. Schizophrenia was the most prevalent diagnosis (56.6%), followed by depression (40%) and bipolar disorder (3.4%). Common comorbidities included obesity/overweight, high blood pressure, and sinus tachycardia. A total of 330 ECT sessions were conducted, with an average of 11 sessions per patient, and 10 patients underwent multiple treatment courses. The reported adverse events included arterial hypertension, agitation, tachycardia, and shivering. : This study underlines the safety and effectiveness of ECT when patients are closely monitored. Our results are consistent with the global data, suggesting that ECT is a good treatment option for severe psychiatric conditions with a manageable incidence of adverse events.
电休克疗法(ECT)是一种针对各种精神障碍的成熟治疗方法。这项回顾性研究评估了罗马尼亚锡比乌“格奥尔基·普雷达博士”临床精神病医院两年期间ECT的麻醉实践、患者特征和治疗结果。
从2022年3月到2024年7月,我们机构的神经科学科研团队对接受ECT治疗的患者进行了一项回顾性观察研究。评估和治疗方案涉及来自全国各地的患者。该研究纳入了30名年龄在22岁至67岁之间、平均年龄为39.4岁的患者;其中57%为男性。大多数患者(68%)居住在城市地区,80%来自不同的县。精神分裂症是最常见的诊断(56.6%),其次是抑郁症(40%)和双相情感障碍(3.4%)。常见的合并症包括肥胖/超重、高血压和窦性心动过速。共进行了330次ECT治疗,每位患者平均11次,10名患者接受了多个疗程的治疗。报告的不良事件包括动脉高血压、激动、心动过速和寒战。
这项研究强调了在对患者进行密切监测时ECT的安全性和有效性。我们的结果与全球数据一致,表明ECT是治疗严重精神疾病的一个良好选择,不良事件发生率可控。